Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study [Phase 2]
Phase II single-arm study evaluating pemetrexed plus erlotinib as salvage therapy in metastatic biliary tract cancer after failure of gemcit…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer [Phase 3]
Phase 3 trial comparing gemcitabine plus capecitabine versus capecitabine alone in curatively resected biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2 [Phase 2]
Phase 2 trial updating the combination of RC48-ADC with Envolizumab in locally advanced or metastatic biliary tract cancer with positive HER…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC [Phase 2, Phase 3]
Phase 2/3 trial evaluating gemcitabine plus cisplatin with or without bintrafusp alfa (M7824) in first-line biliary tract cancer; study term…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating the combination of radiotherapy with anti-PD-1 immunotherapy for unresectable biliary tract cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for PT-112 combined with gemcitabine in advanced solid tumors (Phase 1/2) ongoing for biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC [Phase 1, Phase 2]
Open-label Phase I/II trial evaluating the PLENA regimen for unresectable pancreatic cancer or biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating allogeneic NK cells (SMT-NK) with pembrolizumab in advanced biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors [Phase 2]
Phase 2 trial evaluating tisleizumab with lenvatinib and XELOX in first-line treatment of advanced unresectable biliary tract tumors.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) [Phase 2]
Phase 2 trial of M7824 monotherapy in second-line biliary tract cancers (cholangiocarcinoma and gallbladder cancer) has completed with resul…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating MRG003 for EGFR-positive advanced/metastatic biliary tract cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update for MRG002 in HER2-positive biliary tract cancer (advanced/metastatic, unresectable).
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: SHR-1210 in Combination With GEMOX in Patients With Advanced BTC [Phase 2]
Phase 2 trial of SHR-1210 combined with GEMOX in advanced biliary tract cancer and cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer [Phase 2]
A Phase 2 trial evaluating nivolumab with gemcitabine/cisplatin or with ipilimumab for advanced unresectable biliary tract cancer has comple…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer [Phase 2, Phase 3]
Clinical trial update for varlitinib in combination with capecitabine in biliary tract cancer (Phase 2/Phase 3) has completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer [Phase 2]
Phase 2 trial update of lenvatinib in previously treated advanced biliary tract cancer shows completed status; investigational targeted ther…
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating apatinib plus camrelizumab in previously treated advanced biliary tract cancer shows completed status.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Programs To Support You During Chemotherapy [NA]
A completed clinical trial sponsored by Wake Forest University Health Sciences focused on providing support during chemotherapy, with result…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 study evaluating ramucirumab or merestinib in advanced or metastatic biliary tract cancer; results were posted in February 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: FOLFIRINOX for 2nd-line Treatment of BTC [Phase 2]
Phase 2 trial evaluating FOLFIRINOX as second-line treatment for biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Phase 1/2 Study of SC-43 in Combination With Cisplatin [Phase 1, Phase 2]
Phase 1/2 study investigating SC-43 in combination with cisplatin in advanced cancers including non-small cell lung cancer and biliary tract…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma [Phase 2]
Phase 2 trial evaluating nab-paclitaxel plus S-1 as first-line treatment for advanced biliary tract adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Trastuzumab in HER2-positive Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial of trastuzumab in HER2-positive biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer [Phase 2]
Phase II study comparing nab-paclitaxel plus cisplatin vs gemcitabine plus cisplatin as first-line therapy for advanced biliary tract cancer…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy [Phase 2]
Phase 2 study of lenvatinib (E7080) in unresectable biliary tract cancer after failure of gemcitabine-based therapy has completed with poste…